Prevalence of persistent SARS-CoV-2 in a large community surveillance study
Persistent SARS-CoV-2 infections may act as viral reservoirs that could seed future outbreaks 1–5, give rise to highly divergent lineages 6–8, and contribute to cases with post-acute COVID-19 sequelae (Long Covid) 9,10. However, the population prevalence of persistent infections, their viral load ki...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Journal article |
Language: | English |
Published: |
Springer Nature
2024
|
_version_ | 1797113155994779648 |
---|---|
author | Ghafari, M Hall, M Golubchik, T Ayoubkhani, D House, T Macintyre-Cockett, G Fryer, HR Thomson, L Nurtay, A Kemp, SA Ferretti, L Buck, D Green, A Trebes, A Piazza, P Lonie, L Studley, R Rourke, E Smith, D Bashton, M Nelson, A Crown, M McCann, C Young, GR Nunes dos Santos, RA Richards, Z Tariq, A Cahuantzi, R Barrett, J Fraser, C Bonsall, D Walker, AS Lythgoe, K |
author2 | Wellcome Sanger Institute COVID-19 Surveillance Team |
author_facet | Wellcome Sanger Institute COVID-19 Surveillance Team Ghafari, M Hall, M Golubchik, T Ayoubkhani, D House, T Macintyre-Cockett, G Fryer, HR Thomson, L Nurtay, A Kemp, SA Ferretti, L Buck, D Green, A Trebes, A Piazza, P Lonie, L Studley, R Rourke, E Smith, D Bashton, M Nelson, A Crown, M McCann, C Young, GR Nunes dos Santos, RA Richards, Z Tariq, A Cahuantzi, R Barrett, J Fraser, C Bonsall, D Walker, AS Lythgoe, K |
author_sort | Ghafari, M |
collection | OXFORD |
description | Persistent SARS-CoV-2 infections may act as viral reservoirs that could seed future outbreaks 1–5, give rise to highly divergent lineages 6–8, and contribute to cases with post-acute COVID-19 sequelae (Long Covid) 9,10. However, the population prevalence of persistent infections, their viral load kinetics, and evolutionary dynamics over the course of infections remain largely unknown. Using viral sequence data collected as part of a national infection survey, we identified 381 individuals with SARS-CoV-2 RNA at high titre persisting for at least 30 days, of which 54 had viral RNA persisting at least 60 days. We refer to these as ‘persistent infections’ since available evidence suggests they represent ongoing viral replication, although the persistence of non-replicating RNA cannot be ruled out in all. Persistently infected individuals had more than 50% higher odds of self-reporting Long Covid compared to non-persistently infected individuals. We estimate that 0.1- 0.5% of infections may become persistent with typically rebounding high viral loads and last for at least 60 days. In some individuals, we identified many viral amino acid substitutions, indicating periods of strong positive selection, while others had no consensus change in the sequences for prolonged periods, consistent with weak selection. Substitutions included mutations that are lineage-defining for SARS-CoV-2 variants, at target sites for monoclonal antibodies, and/or commonly found in immunocompromised patients 11–14. This work has significant implications for understanding and characterising SARS-CoV-2 infection, epidemiology, and evolution. |
first_indexed | 2024-03-07T08:18:55Z |
format | Journal article |
id | oxford-uuid:9058a2db-4a64-480b-99f5-dfc8bd8edd2e |
institution | University of Oxford |
language | English |
last_indexed | 2024-04-23T08:24:20Z |
publishDate | 2024 |
publisher | Springer Nature |
record_format | dspace |
spelling | oxford-uuid:9058a2db-4a64-480b-99f5-dfc8bd8edd2e2024-04-10T09:47:04ZPrevalence of persistent SARS-CoV-2 in a large community surveillance studyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:9058a2db-4a64-480b-99f5-dfc8bd8edd2eEnglishSymplectic ElementsSpringer Nature2024Ghafari, MHall, MGolubchik, TAyoubkhani, DHouse, TMacintyre-Cockett, GFryer, HRThomson, LNurtay, AKemp, SAFerretti, LBuck, DGreen, ATrebes, APiazza, PLonie, LStudley, RRourke, ESmith, DBashton, MNelson, ACrown, MMcCann, CYoung, GRNunes dos Santos, RARichards, ZTariq, ACahuantzi, RBarrett, JFraser, CBonsall, DWalker, ASLythgoe, KWellcome Sanger Institute COVID-19 Surveillance TeamCOVID-19 Infection Survey GroupThe COVID-19 Genomics UK (COG-UK) ConsortiumPersistent SARS-CoV-2 infections may act as viral reservoirs that could seed future outbreaks 1–5, give rise to highly divergent lineages 6–8, and contribute to cases with post-acute COVID-19 sequelae (Long Covid) 9,10. However, the population prevalence of persistent infections, their viral load kinetics, and evolutionary dynamics over the course of infections remain largely unknown. Using viral sequence data collected as part of a national infection survey, we identified 381 individuals with SARS-CoV-2 RNA at high titre persisting for at least 30 days, of which 54 had viral RNA persisting at least 60 days. We refer to these as ‘persistent infections’ since available evidence suggests they represent ongoing viral replication, although the persistence of non-replicating RNA cannot be ruled out in all. Persistently infected individuals had more than 50% higher odds of self-reporting Long Covid compared to non-persistently infected individuals. We estimate that 0.1- 0.5% of infections may become persistent with typically rebounding high viral loads and last for at least 60 days. In some individuals, we identified many viral amino acid substitutions, indicating periods of strong positive selection, while others had no consensus change in the sequences for prolonged periods, consistent with weak selection. Substitutions included mutations that are lineage-defining for SARS-CoV-2 variants, at target sites for monoclonal antibodies, and/or commonly found in immunocompromised patients 11–14. This work has significant implications for understanding and characterising SARS-CoV-2 infection, epidemiology, and evolution. |
spellingShingle | Ghafari, M Hall, M Golubchik, T Ayoubkhani, D House, T Macintyre-Cockett, G Fryer, HR Thomson, L Nurtay, A Kemp, SA Ferretti, L Buck, D Green, A Trebes, A Piazza, P Lonie, L Studley, R Rourke, E Smith, D Bashton, M Nelson, A Crown, M McCann, C Young, GR Nunes dos Santos, RA Richards, Z Tariq, A Cahuantzi, R Barrett, J Fraser, C Bonsall, D Walker, AS Lythgoe, K Prevalence of persistent SARS-CoV-2 in a large community surveillance study |
title | Prevalence of persistent SARS-CoV-2 in a large community surveillance study |
title_full | Prevalence of persistent SARS-CoV-2 in a large community surveillance study |
title_fullStr | Prevalence of persistent SARS-CoV-2 in a large community surveillance study |
title_full_unstemmed | Prevalence of persistent SARS-CoV-2 in a large community surveillance study |
title_short | Prevalence of persistent SARS-CoV-2 in a large community surveillance study |
title_sort | prevalence of persistent sars cov 2 in a large community surveillance study |
work_keys_str_mv | AT ghafarim prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy AT hallm prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy AT golubchikt prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy AT ayoubkhanid prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy AT houset prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy AT macintyrecockettg prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy AT fryerhr prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy AT thomsonl prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy AT nurtaya prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy AT kempsa prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy AT ferrettil prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy AT buckd prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy AT greena prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy AT trebesa prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy AT piazzap prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy AT loniel prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy AT studleyr prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy AT rourkee prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy AT smithd prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy AT bashtonm prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy AT nelsona prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy AT crownm prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy AT mccannc prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy AT younggr prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy AT nunesdossantosra prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy AT richardsz prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy AT tariqa prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy AT cahuantzir prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy AT barrettj prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy AT fraserc prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy AT bonsalld prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy AT walkeras prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy AT lythgoek prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy |